Health Care & Life Sciences » Pharmaceuticals | AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values NZD Thousands.
2015
2016
2017
2018
2019
Sales/Revenue
56,241.00
64,014.00
69,205.00
80,071.00
85,127
Cost of Goods Sold (COGS) incl. D&A
35,083.00
40,435.00
43,533.00
46,220.00
44,716
Gross Income
21,158.00
23,579.00
25,672.00
33,851.00
40,411
SG&A Expense
28,393.00
34,530.00
42,716.00
44,731.00
36,011
EBIT
7,235.00
10,951.00
-
10,880.00
4,400
Unusual Expense
-
2,623.00
550.00
-
417
Non Operating Income/Expense
2,196.00
3,700.00
1,399.00
3,053.00
387
Interest Expense
3,759.00
3,424.00
3,168.00
3,470.00
5,376
Pretax Income
13,155.00
13,007.00
17,916.00
11,172.00
1,738
Income Tax
282.00
42.00
58.00
58.00
168
Equity in Affiliates
-
302.00
414.00
1,494.00
521
Consolidated Net Income
12,873.00
13,267.00
18,388.00
12,724.00
2,427
Net Income
12,873.00
13,267.00
18,388.00
12,724.00
2,427
Net Income After Extraordinaries
12,873.00
13,267.00
18,388.00
12,724.00
2,427
Net Income Available to Common
12,873.00
13,267.00
18,388.00
12,724.00
3,362
EPS (Basic)
0.13
0.48
0.19
0.13
0.03
Basic Shares Outstanding
96,000.00
27,576.20
96,837.80
97,248.90
97,308
EPS (Diluted)
0.13
0.48
0.19
0.13
0.03
Diluted Shares Outstanding
96,000.00
27,576.20
96,837.80
97,248.90
97,308
EBITDA
7,007.00
10,683.00
16,718.00
10,540.00
4,719
Non-Operating Interest Income
35.00
291.00
347.00
125.00
42

About AFT Pharmaceuticals

View Profile
Address
Nielsen House
Auckland AU 0622
New Zealand
Employees -
Website http://www.aftpharm.com
Updated 07/08/2019
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic, Coco-Scalp, Maxiclear, Eyecare Hub, and Allergy Hub. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.